
Stephen L. Rawlings
Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1642, 1643, 1646 |
| Total Applications | 1483 |
| Issued Applications | 633 |
| Pending Applications | 153 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6304336
[patent_doc_number] => 20100068717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'CANCER THERAPY PROGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/524845
[patent_app_country] => US
[patent_app_date] => 2008-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11004
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068717.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524845
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524845 | CANCER THERAPY PROGNOSIS | Jan 29, 2008 | Abandoned |
Array
(
[id] => 6220629
[patent_doc_number] => 20100055724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'METHODS OF DETECTING AUTOANTIBODIES FOR DIAGNOSING AND CHARACTERIZING DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/524398
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16742
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055724.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524398
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524398 | METHODS OF DETECTING AUTOANTIBODIES FOR DIAGNOSING AND CHARACTERIZING DISORDERS | Jan 27, 2008 | Abandoned |
Array
(
[id] => 4778783
[patent_doc_number] => 20080286781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer'
[patent_app_type] => utility
[patent_app_number] => 12/011459
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 41242
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286781.pdf
[firstpage_image] =>[orig_patent_app_number] => 12011459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/011459 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | Jan 23, 2008 | Abandoned |
Array
(
[id] => 6430972
[patent_doc_number] => 20100143358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Use of Antibody Conjugates'
[patent_app_type] => utility
[patent_app_number] => 12/523438
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10269
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143358.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523438
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523438 | Use of Antibody Conjugates | Jan 21, 2008 | Abandoned |
Array
(
[id] => 5367859
[patent_doc_number] => 20090305418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'CELL THERAPY METHOD FOR THE TREATMENT OF TUMORS'
[patent_app_type] => utility
[patent_app_number] => 12/014863
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 14700
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305418.pdf
[firstpage_image] =>[orig_patent_app_number] => 12014863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/014863 | Cell therapy method for the treatment of tumors | Jan 15, 2008 | Issued |
Array
(
[id] => 5348851
[patent_doc_number] => 20090004212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Tumour vaccines for MUC1-positive carcinomas'
[patent_app_type] => utility
[patent_app_number] => 12/008733
[patent_app_country] => US
[patent_app_date] => 2008-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8292
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004212.pdf
[firstpage_image] =>[orig_patent_app_number] => 12008733
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/008733 | Tumour vaccines for MUC1-positive carcinomas | Jan 13, 2008 | Abandoned |
Array
(
[id] => 4786147
[patent_doc_number] => 20080139476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'CASPASE-8 INTERACTING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/970986
[patent_app_country] => US
[patent_app_date] => 2008-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 26461
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11970986
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/970986 | CASPASE-8 INTERACTING PROTEINS | Jan 7, 2008 | Abandoned |
Array
(
[id] => 4759924
[patent_doc_number] => 20080312150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Treatment and analysis of proliferative disorders'
[patent_app_type] => utility
[patent_app_number] => 12/005171
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9230
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312150.pdf
[firstpage_image] =>[orig_patent_app_number] => 12005171
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/005171 | Treatment and analysis of proliferative disorders | Dec 20, 2007 | Abandoned |
Array
(
[id] => 6237437
[patent_doc_number] => 20100267933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'PURIFICATION OF PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/448004
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16000
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448004
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448004 | PURIFICATION OF PROTEINS | Dec 19, 2007 | Abandoned |
Array
(
[id] => 4778782
[patent_doc_number] => 20080286780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers'
[patent_app_type] => utility
[patent_app_number] => 12/002783
[patent_app_country] => US
[patent_app_date] => 2007-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34680
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286780.pdf
[firstpage_image] =>[orig_patent_app_number] => 12002783
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/002783 | Compositions and methods for the identification, assessment, prevention and therapy of human cancers | Dec 16, 2007 | Issued |
Array
(
[id] => 4820367
[patent_doc_number] => 20080226621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/958099
[patent_app_country] => US
[patent_app_date] => 2007-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 29568
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226621.pdf
[firstpage_image] =>[orig_patent_app_number] => 11958099
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/958099 | Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases | Dec 16, 2007 | Issued |
Array
(
[id] => 4765835
[patent_doc_number] => 20080177047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Single-chain Antibodies Against Human Insulin-Like Growth Factor I Receptor: Expression, Purification, and Effect on Tumor Growth'
[patent_app_type] => utility
[patent_app_number] => 11/957899
[patent_app_country] => US
[patent_app_date] => 2007-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4253
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20080177047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11957899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/957899 | Single-chain Antibodies Against Human Insulin-Like Growth Factor I Receptor: Expression, Purification, and Effect on Tumor Growth | Dec 16, 2007 | Abandoned |
Array
(
[id] => 4595451
[patent_doc_number] => 07981610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)'
[patent_app_type] => utility
[patent_app_number] => 11/955322
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24619
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981610.pdf
[firstpage_image] =>[orig_patent_app_number] => 11955322
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/955322 | ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) | Dec 11, 2007 | Issued |
Array
(
[id] => 4764630
[patent_doc_number] => 20080175841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Antagonistic Anti-hTNFSF13b Human Antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/952363
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12914
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175841.pdf
[firstpage_image] =>[orig_patent_app_number] => 11952363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/952363 | Antagonistic anti-hTNFSF13b human antibodies | Dec 6, 2007 | Issued |
Array
(
[id] => 5970978
[patent_doc_number] => 20110151579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'Secreted Epithelial Stromal-1 Molecules and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/951797
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34516
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20110151579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11951797
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/951797 | Secreted Epithelial Stromal-1 Molecules and Uses Thereof | Dec 5, 2007 | Abandoned |
Array
(
[id] => 4955377
[patent_doc_number] => 20080188401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/948659
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41493
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11948659
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/948659 | Anti-human IL-6 antibodies | Nov 29, 2007 | Issued |
Array
(
[id] => 4786146
[patent_doc_number] => 20080139475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'INHIBITION OF ATF2 ACTIVITY TO TREAT CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/945133
[patent_app_country] => US
[patent_app_date] => 2007-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28750
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139475.pdf
[firstpage_image] =>[orig_patent_app_number] => 11945133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/945133 | Inhibition of ATF2 activity to treat cancer | Nov 25, 2007 | Issued |
Array
(
[id] => 10018492
[patent_doc_number] => 09060961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Molecules and methods for treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 12/446953
[patent_app_country] => US
[patent_app_date] => 2007-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 59
[patent_no_of_words] => 28929
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/446953 | Molecules and methods for treatment and detection of cancer | Nov 8, 2007 | Issued |
Array
(
[id] => 4778286
[patent_doc_number] => 20080286284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Compositions of PSMA antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/983372
[patent_app_country] => US
[patent_app_date] => 2007-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 37928
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11983372
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/983372 | Compositions of PSMA antibodies | Nov 6, 2007 | Issued |
Array
(
[id] => 5928897
[patent_doc_number] => 20110038856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/513313
[patent_app_country] => US
[patent_app_date] => 2007-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 31680
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038856.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513313
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513313 | METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES | Nov 1, 2007 | Abandoned |